Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lois H. Yoshida

Novel Adenovirus Type 5 Vaccine Platform Induces Cellular Immunity Against HIV-1 Gag, Pol, Nef Despite the Presence of Ad5 Immunity

Vaccine

English

A Preliminary and Comparative Evaluation of a Novel Ad5 [E1-, E2b-] Recombinant-Based Vaccine Used to Induce Cell Mediated Immune Responses

English

Related publications

Dendritic Cells Infected by Recombinant Rabies Virus Vaccine Vector Expressing HIV-1 Gag Are Immunogenic Even in the Presence of Vector-Specific Immunity

English

Intravascular Naked DNA Vaccine Encoding Glycoprotein B Induces Protective Humoral and Cellular Immunity Against Herpes Simplex Virus Type 1 Infection in Mice

English

Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1

Frontiers in Immunology

Allergy

Immunology

2018

English

HIV Gag Polyprotein; HIV P27 (Nef)

Science-Business eXchange

2009

English

Ipr1 Modified BCG as a Novel Vaccine Induces Stronger Immunity Than BCG Against Tuberculosis Infection in Mice

Molecular Medicine Reports

English

A Trivalent Recombinant Ad5 Gag/Pol/Nef Vaccine Fails to Protect Rhesus Macaques From Infection or Control Virus Replication After a Limiting-Dose Heterologous SIV Challenge

English

Mechanism of Ad5 Vaccine Immunity and Toxicity: Fiber Shaft Targeting of Dendritic Cells

English

Coadministration of HIV Vaccine Vectors With Vaccinia Viruses Expressing IL-15 but Not IL-2 Induces Long-Lasting Cellular Immunity

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2003

English

Nef Modulates the Immunogenicity of Gag Encoded in a Non-Infectious HIV DNA Vaccine

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Lois H. Yoshida

Novel Adenovirus Type 5 Vaccine Platform Induces Cellular Immunity Against HIV-1 Gag, Pol, Nef Despite the Presence of Ad5 Immunity

A Preliminary and Comparative Evaluation of a Novel Ad5 [E1-, E2b-] Recombinant-Based Vaccine Used to Induce Cell Mediated Immune Responses

Related publications

Dendritic Cells Infected by Recombinant Rabies Virus Vaccine Vector Expressing HIV-1 Gag Are Immunogenic Even in the Presence of Vector-Specific Immunity

Intravascular Naked DNA Vaccine Encoding Glycoprotein B Induces Protective Humoral and Cellular Immunity Against Herpes Simplex Virus Type 1 Infection in Mice

Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1

HIV Gag Polyprotein; HIV P27 (Nef)

Ipr1 Modified BCG as a Novel Vaccine Induces Stronger Immunity Than BCG Against Tuberculosis Infection in Mice

A Trivalent Recombinant Ad5 Gag/Pol/Nef Vaccine Fails to Protect Rhesus Macaques From Infection or Control Virus Replication After a Limiting-Dose Heterologous SIV Challenge

Mechanism of Ad5 Vaccine Immunity and Toxicity: Fiber Shaft Targeting of Dendritic Cells

Coadministration of HIV Vaccine Vectors With Vaccinia Viruses Expressing IL-15 but Not IL-2 Induces Long-Lasting Cellular Immunity

Nef Modulates the Immunogenicity of Gag Encoded in a Non-Infectious HIV DNA Vaccine